Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck: Secondary Analysis of a Phase 2 Clinical Trial.

ABSTRACT:

SUBMITTER: Ferrarotto R 

PROVIDER: S-EPMC10401391 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature